HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project.

Abstract
For respiratory tract infection (RTI), antibiotics should have proven clinical efficacy against the major pathogens involved-Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. As the pattern of resistance to antimicrobials changes, the clinical effectiveness of these agents should be reviewed. However, clinical trials are time consuming and costly, and alternative ways of predicting clinical efficacy using susceptibility data have been investigated. Pharmacodynamic breakpoints have been suggested as providing the link between susceptibility data and clinical effectiveness and this is supported by emerging clinical evidence. Thus, using the data collected in the Alexander Project, guidelines for the treatment of RTI can be developed which reflect the local resistance profile and maximize the chances of clinical success.
AuthorsJ Garau
JournalJournal of chemotherapy (Florence, Italy) (J Chemother) Vol. 11 Suppl 1 Pg. 51-5 (Feb 1999) ISSN: 1120-009X [Print] ITALY
PMID10207774 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Decision Making
  • Drug Resistance, Microbial
  • Evidence-Based Medicine
  • Haemophilus Infections (drug therapy)
  • Haemophilus influenzae (drug effects)
  • Humans
  • Moraxella (Branhamella) catarrhalis (drug effects)
  • Neisseriaceae Infections (drug therapy)
  • Pneumococcal Infections (drug therapy)
  • Population Surveillance
  • Respiratory Tract Infections (drug therapy)
  • Streptococcus pneumoniae (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: